![Frontiers | Incidence and Antiseizure Medications of Post-stroke Epilepsy in Umbria: A Population-Based Study Using Healthcare Administrative Databases | Neurology Frontiers | Incidence and Antiseizure Medications of Post-stroke Epilepsy in Umbria: A Population-Based Study Using Healthcare Administrative Databases | Neurology](https://www.frontiersin.org/files/Articles/800524/fneur-12-800524-HTML/image_m/fneur-12-800524-g001.jpg)
Frontiers | Incidence and Antiseizure Medications of Post-stroke Epilepsy in Umbria: A Population-Based Study Using Healthcare Administrative Databases | Neurology
![ORPHELIA Pharma and Ethypharm sign a licensing agreement for the development and marketing of Kigabeq®... ORPHELIA Pharma and Ethypharm sign a licensing agreement for the development and marketing of Kigabeq®...](https://d29md5j3ph8xfz.cloudfront.net/100_percent/upload/Content/114686/a58ef21266a2981e18b3852c02301435_1_.png)
ORPHELIA Pharma and Ethypharm sign a licensing agreement for the development and marketing of Kigabeq®...
![Off-label use and manipulations of antiepileptic drugs in children: Analysis of the outpatient prescriptions in a tertiary center - Epilepsy & Behavior Off-label use and manipulations of antiepileptic drugs in children: Analysis of the outpatient prescriptions in a tertiary center - Epilepsy & Behavior](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/42ad6d45-a1d1-46f1-b35f-9958e2223d74/gr1_lrg.jpg)